Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Strata Critical Medical Q3 2026 Results: Net Loss of $7.62M

Strata Critical Medical, Inc. reported a net loss of $7.6 million for the third quarter of 2026, compared to a net income of $57.4 million in the prior year period, which was significantly bolstered by discontinued operations. Revenue grew to $74.1 million from $49.3 million year-over-year, while the company maintained a cash and cash equivalents balance of $35.1 million as of September 30, 2026.

Watch the Strata Critical Medical, Inc. earnings callFull call on the ALFA USA YouTube channel
Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue74.149.3
Gross profit16.810.7
Profit before tax-7.6-9.7
Net income-7.657.4
EPS (diluted, $ a share)$-0.09$0.70

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+50.3%
Gross margin22.7%
Operating margin-5.2%
Source

10-Q filed with the SEC, NASDAQ: SRTA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Strata Critical Medical, Inc.: key numbers

Share price
$5.42Close, Nov 16
Market cap
$484M
Shares outstanding
89.32MLatest SEC cover page
Sector
Energy & Transportation
Industry
Transportation ServicesSIC 4700

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Strata Critical Medical, Inc.

All →
8:12 AM ET 8-K
Financial Results

Strata Critical Medical Financial Results

Strata Critical Medical reported Q3 2026 financial results with revenue increasing 50.3% year-over-year to $74.1 million, driven by significant growth in its Clinical segment. The company also announced a new $20 million share repurchase authorization to be executed alongside its ongoing M&A strategy.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.